Renalytix Plc (AIM:RENX)
London · Delayed Price · Currency is GBP · Price in GBX 1.860
-0.040 (-2.11%)
Jun 17, 2026, 3:34 PM GMT
Renalytix Cash Flow Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Net Income | -19.9 | -20.4 | -45.5 | -45.61 | -45.28 | -34.73 |
Depreciation & Amortization | - | - | 0.2 | 0.31 | 0.29 | 0.2 |
Other Amortization | - | - | 2.3 | 0.2 | 0.2 | 0.09 |
Loss (Gain) From Sale of Assets | - | - | - | - | - | -0.05 |
Asset Writedown & Restructuring Costs | - | - | 11.1 | - | - | - |
Loss (Gain) From Sale of Investments | 0.3 | 0.5 | 0.6 | 1.28 | 5.9 | -6.5 |
Loss (Gain) on Equity Investments | - | - | - | 0.01 | -0.01 | 2.11 |
Stock-Based Compensation | 3.5 | 3.2 | 1.1 | 2.93 | 4.62 | 2.66 |
Other Operating Activities | 2 | 2.1 | 3.7 | 1.04 | -11.46 | 4.18 |
Change in Accounts Receivable | -0.7 | 0.1 | 0.1 | 0.13 | -0.31 | -0.59 |
Change in Inventory | - | 0.1 | 0.4 | - | - | - |
Change in Accounts Payable | 0.3 | -2.7 | -4 | 0.45 | 2.14 | 0.78 |
Change in Unearned Revenue | - | - | - | -0.05 | -0.08 | 0.12 |
Change in Other Net Operating Assets | 1.5 | -0.8 | 0.2 | 5.22 | -1.95 | 3.33 |
Operating Cash Flow | -13 | -17.9 | -29.8 | -34.09 | -45.92 | -28.4 |
Capital Expenditures | -0.1 | - | - | - | -0.56 | -0.77 |
Sale (Purchase) of Intangibles | - | - | - | - | -0.11 | -0.75 |
Investment in Securities | - | - | 0.1 | - | - | 1 |
Other Investing Activities | - | - | - | - | - | -0.23 |
Investing Cash Flow | -0.1 | - | 0.1 | - | -0.66 | -0.75 |
Long-Term Debt Issued | - | - | - | - | 18.02 | - |
Total Debt Issued | - | - | - | - | 18.02 | - |
Long-Term Debt Repaid | - | -3.5 | -1.9 | -3.18 | - | - |
Total Debt Repaid | -4.2 | -3.5 | -1.9 | -3.18 | - | - |
Net Debt Issued (Repaid) | -4.2 | -3.5 | -1.9 | -3.18 | 18.02 | - |
Issuance of Common Stock | 13.8 | 19.5 | 11.9 | 20.56 | 9.21 | 79.55 |
Other Financing Activities | - | - | - | -0.99 | -1.6 | -2.31 |
Financing Cash Flow | 9.6 | 16 | 10 | 16.39 | 25.63 | 77.24 |
Foreign Exchange Rate Adjustments | 0.4 | 0.8 | -0.3 | 1.05 | -2.84 | 3.75 |
Net Cash Flow | -3.1 | -1.1 | -20 | -16.65 | -23.8 | 51.84 |
Free Cash Flow | -13.1 | -17.9 | -29.8 | -34.09 | -46.48 | -29.17 |
Free Cash Flow Margin | -396.97% | -596.67% | -1295.65% | -1001.62% | -1565.02% | -1956.54% |
Free Cash Flow Per Share | -0.03 | -0.07 | -0.28 | -0.41 | -0.63 | -0.41 |
Levered Free Cash Flow | - | -11.24 | -18.48 | -17.31 | -30.57 | -16.41 |
Unlevered Free Cash Flow | - | -10.93 | -18.48 | -17.31 | -30.57 | -16.41 |
Change in Working Capital | 1.1 | -3.3 | -3.3 | 5.75 | -0.19 | 3.64 |